Home
|
News
|
Departments
|
Editorial Board
|
Contact
|
Subscribe
|
Advertise
|
About
RSS
Home
News
Departments
Feature
Commentary
Ongoing Clinical Trials
Legal Issues
Malpractice News
FDA News
World Literature Review
Renal Nutrition Update
Your Money
Your Practice
Reviews
Urology
Bladder Cancer
BPH
Erectile Dysfunction
Kidney Cancer
Kidney Stones
Overactive Bladder
Premature Ejaculation
Prostate Cancer
PSA
Reproductive Medicine
Urinary Incontinence
UTI
Nephrology
Acute Renal Failure
Anemia
CKD
Contrast Nephropathy
CVD
Diabetes
Diabetic Nephropathy
FSGS
Hemodialysis
Hypertension
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation
Archive
Jobs
Advertise
Rate card
Subscribe
Drug Info
Prostate Cancer Articles
HIFU Effective for Long-Term Prostate Cancer Control
Jody A. Charnow
June 03, 2008
High-intensity focused ultrasound (HIFU), a minimally invasive treatment for localized prostate cancer, achieves effective long-term disease control in patients with low- and intermediate-risk tumors, according to researchers in France and Germany.
EBRT for Prostate Cancer Hikes Risk of Secondary Cancers
Jody A. Charnow
May 23, 2008
ORLANDO, Fla.—External beam radiation therapy (EBRT) increases the risk of secondary malignancies relative to radical prostatectomy in men with localized prostate cancer, data show.
Prostate Tumor Biology Differs By Race: Study
John Schieszer
May 16, 2008
SAN DIEGO - Genetic analyses suggest that prostate cancer is distinctly different in African-American men compared with European-American men, according to researchers at the National Cancer Institute (NCI) in Bethesda, Md.
Sextant Biopsy Alone May Miss Tumors
Jody A. Charnow
May 06, 2008
PROSTATE BIOPSIES in men with a PSA level of 4.01-10.0 ng/mL and normal findings on digital rectal examination (DRE) should include lateral cores in addition to the sextant biopsy, according to investigators.
NSAIDs Lower PCa Death Risk
Jody A. Charnow
May 06, 2008
SAN FRANCISCO—High exposure to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is asso-ciated with decreased prostate cancer-specific mortality, according to study findings presented here at the 2008 Genitourinary Cancers Symposium.
Lower PSAV Threshold Useful
Jody A. Charnow
May 06, 2008
SAN FRANCISCO—A PSA velocity (PSAV) threshold of 0.4 ng/mL per year can distinguish between clinically significant and insignificant prostate cancer, new data suggest.
Untreated PCa Seldom Fatal in Elderly
Jody A. Charnow
May 06, 2008
SAN FRANCISCO—Few elderly men with localized prostate cancer will die from the malignancy after 10 years even in treatment is delayed, so active surveillance for these patients may be a reasonable option, according to researchers.
Study: Combo Promising for Metastatic AIPC
Jody A. Charnow
May 06, 2008
SAN FRANCISCO—Adding thalidomide and bevacizumab to docetaxel may hold promise for treating patients with metastatic androgen-independent prostate cancer (AIPC), investigators report.
Repeat PSA Tests May Aid Prostate Biopsy Decisions
Jody A. Charnow
May 06, 2008
Following an initial PSA test result of 3.0-19.99 ng/mL in men aged 50-70 years, a repeat PSA test within seven weeks allows for more accurate assessment as to whether a biopsy will reveal prostate cancer, a British team reports.
PCa Chemotherapy Holidays Possible
John Schieszer
May 06, 2008
INTERMITTENT chemotherapy may be an option for some men with androgen-independent prostate cancer (AIPC), researchers found.
« Previous
Next »
Most Popular
Success with Replacement Bladders
Gene Therapy Shows Promise for ED
Polypharmacy Common in Women with CKD
Antihypertensive Agents Found to Slow GFR Decline
Monthly Hematide Dose Maintains Hb Levels
Home Dialysis Used More At Larger Centers
Intensive Glucose Control Found to Protect Kidneys
Study Defines Post-Tx Limb Syndrome
Drug's Renoprotective Effect Shown
HoLEP Effectiveness Independent of Prostate Size
Most Emailed
Success with Replacement Bladders
Gene Therapy Shows Promise for ED
Antihypertensive Agents Found to Slow GFR Decline
Polypharmacy Common in Women with CKD
Home Dialysis Used More At Larger Centers
Intensive Glucose Control Found to Protect Kidneys
Study Shows Advantages of Degarelix
Monthly Hematide Dose Maintains Hb Levels
Study Defines Post-Tx Limb Syndrome
Drug's Renoprotective Effect Shown
Most Recent
Monthly Hematide Dose Maintains Hb Levels
Success with Replacement Bladders
Gene Therapy Shows Promise for ED
Antihypertensive Agents Found to Slow GFR Decline
Polypharmacy Common in Women with CKD
Home Dialysis Used More At Larger Centers
Intensive Glucose Control Found to Protect Kidneys
Study Defines Post-Tx Limb Syndrome
Drug's Renoprotective Effect Shown
HoLEP Effectiveness Independent of Prostate Size
Popular Tags
Acute Renal Failure
Anemia
Bladder Cancer
BPH
CKD
CVD
Diabetes
Diabetic Nephropathy
Epidemiology
Erectile Dysfunction
Hemodialysis
Hypertension
Kidney Cancer
Kidney Stones
Lupus nephritis
Peritoneal Dialysis
Prostate Cancer
PSA
Reproductive medicine
Transplantation
Urinary Incontinence
UTI
Home
|
News
|
Departments
|
Editorial Board
|
Contact
|
Subscribe
|
Advertise
|
About
From Haymarket Medical the Publishers of: